Cargando…
Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study
Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405875/ https://www.ncbi.nlm.nih.gov/pubmed/34476251 http://dx.doi.org/10.1183/23120541.00379-2021 |
| _version_ | 1783746406077431808 |
|---|---|
| author | Samaranayake, Chinthaka B. Keir, Gregory Slader, Simon A.A. Tseng, T. Tran, Khoa Anderson, James McCann, Andrew McCabe, Colm Upham, John W. |
| author_facet | Samaranayake, Chinthaka B. Keir, Gregory Slader, Simon A.A. Tseng, T. Tran, Khoa Anderson, James McCann, Andrew McCabe, Colm Upham, John W. |
| author_sort | Samaranayake, Chinthaka B. |
| collection | PubMed |
| description | Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX |
| format | Online Article Text |
| id | pubmed-8405875 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Respiratory Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84058752021-09-01 Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study Samaranayake, Chinthaka B. Keir, Gregory Slader, Simon A.A. Tseng, T. Tran, Khoa Anderson, James McCann, Andrew McCabe, Colm Upham, John W. ERJ Open Res Research Letters Assessment of efficacy and safety of DOACs in treatment of pulmonary embolisms in obese patients provides reassurance that treatment with DOACs carries similar rates of recurrent VTE and bleeding complications to warfarin https://bit.ly/2VdrSXX European Respiratory Society 2021-08-31 /pmc/articles/PMC8405875/ /pubmed/34476251 http://dx.doi.org/10.1183/23120541.00379-2021 Text en Copyright ©The authors 2021 https://creativecommons.org/licenses/by-nc/4.0/This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org (mailto:permissions@ersnet.org) |
| spellingShingle | Research Letters Samaranayake, Chinthaka B. Keir, Gregory Slader, Simon A.A. Tseng, T. Tran, Khoa Anderson, James McCann, Andrew McCabe, Colm Upham, John W. Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title | Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title_full | Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title_fullStr | Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title_full_unstemmed | Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title_short | Use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| title_sort | use of direct oral anticoagulants for acute pulmonary embolisms in obesity: a propensity-matched, multicentre case–control study |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405875/ https://www.ncbi.nlm.nih.gov/pubmed/34476251 http://dx.doi.org/10.1183/23120541.00379-2021 |
| work_keys_str_mv | AT samaranayakechinthakab useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT keirgregory useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT sladersimonaa useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT tsengt useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT trankhoa useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT andersonjames useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT mccannandrew useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT mccabecolm useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy AT uphamjohnw useofdirectoralanticoagulantsforacutepulmonaryembolismsinobesityapropensitymatchedmulticentrecasecontrolstudy |